Alicia K. Morgans, Tamim Niazi, Neal D. Shore, Juergen E. Gschwend, Ashley Ross, Thomas A. Hope, Alex Chehrazi-Raffle, Stephane Supiot, Philippe Barthélémy, Andreas Røder, Andrea Juliana Gomes, Bernardo Herrera Imbroda, Matthieu Gratton, Carmen Belen Congregado Ruiz, Heikki Joensuu, Marie-Aude Le Berre, Miryana Dimova-Dobreva, Iris Kuss, Karim Fizazi. "Darolutamide plus androgen deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps5131